Career history of Jeffrey M. Johnston
Former positions of Jeffrey M. Johnston
| Companies | Position | Start | End |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2005-08-31 | 2015-12-31 |
| RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-12-31 | - |
| GSK PLC | Corporate Officer/Principal | - | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Chief Tech/Sci/R&D Officer | - | - |
| Critical Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | 2011-06-19 | - |
| Corporate Officer/Principal | - | 2011-06-19 |
Training of Jeffrey M. Johnston
| Davidson College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey M. Johnston
- Experience
